flurbiprofen has been researched along with Experimental Mammary Neoplasms in 10 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Flurbiprofen did not seem to alter the bioavailability of the chemotherapeutic agents." | 1.26 | Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. ( Bennett, A; Berstock, DA; Carroll, MA, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karmali, RA | 3 |
| McCormick, DL | 1 |
| Moon, RC | 1 |
| Bennett, A | 6 |
| Berstock, DA | 3 |
| Carroll, MA | 1 |
| Houghton, J | 3 |
| Leaper, DJ | 3 |
| French, B | 1 |
| Stamford, IF | 1 |
| French, BT | 1 |
| Marsh, J | 2 |
10 other studies available for flurbiprofen and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione.
Topics: Adenocarcinoma; Animals; Cyclooxygenase Inhibitors; Dinoprostone; Female; Flurbiprofen; Glutathione; | 1984 |
Inhibition of mammary carcinogenesis by flurbiprofen, a non-steroidal antiinflammatory agent.
Topics: Animals; Female; Flurbiprofen; Mammary Neoplasms, Experimental; Methylnitrosourea; Propionates; Rats | 1983 |
Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy.
Topics: Adenocarcinoma; Animals; Biological Availability; Body Weight; Drug Therapy, Combination; Female; Fl | 1982 |
Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
Topics: Adenocarcinoma; Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Mammary Neoplasms, Expe | 1980 |
Reduction by flurbiprofen of primary tumor growth and local metastasis formation in mice.
Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; | 1980 |
Improved anticancer effect by combining cytotoxic drugs with an inhibitor of prostaglandin synthesis.
Topics: Animals; Cyclooxygenase Inhibitors; Drug Synergism; Drug Therapy, Combination; Female; Flurbiprofen; | 1979 |
Cancer growth, response to treatment and survival time in mice: beneficial effect of the prostaglandin synthesis inhibitor flurbiprofen.
Topics: Animals; Drug Evaluation, Preclinical; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; | 1979 |
Breast cancer and prostaglandins: a new approach to treatment.
Topics: Animals; Female; Flurbiprofen; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Recurrence, Loc | 1979 |
Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
Topics: Animals; Antineoplastic Agents; Cyclooxygenase Inhibitors; Dinoprostone; Female; Flurbiprofen; Ibupr | 1986 |
Antitumor activity in a rat mammary adenocarcinoma: the effect of cyclooxygenase inhibitors and immunization against prostaglandin E2.
Topics: Adenocarcinoma; Animals; Antibodies; Antineoplastic Agents; Cell Line; Cyclooxygenase Inhibitors; Di | 1985 |